Terex Corporation (NYSE:TEX) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript October 30, 2025 Terex Corporation beats earnings expectations. Reported EPS is $1.5, ...

Flushing Financial Corporation (NASDAQ:FFIC) Q3 2025 Earnings Call Transcript

Flushing Financial Corporation (NASDAQ: FFIC) Q3 2025 Earnings Call Transcript October 30, 2025 ...

Benjamin Ball Associates Celebrates Strong Client Reviews Highlighting Impact of Executive Coaching and Presentation Training

LONDON, UK – October 22, 2025 – PRESSADVANTAGE – Benjamin Ball Associates, a London-based executive coaching and presentation training firm, has reported strengthened client feedback and announced ...
The Manila Times

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced ...

American Water Works Company, Inc. (AWK) M&A Call Transcript

American Water Works Company, Inc. ( NYSE: AWK) M&A Call October 27, 2025 8:30 AM EDT Good morning, everyone. Welcome to today's conference call to discuss the combination of American Water and ...
Cantech Letter

AITX CEO Steve Reinharz Engages Investors at OTC Markets Virtual Investor Conference

Reinharz Highlights AITX’s Strengthening Financials, AI Innovation, and Long-Term Growth Strategy Detroit, Michigan–(Newsfile ...

Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3

RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...

The Navigator Company, S.A. (POELF) Q3 2025 Earnings Call Transcript

Ladies and gentlemen, welcome to The Navigator Company conference call and webcast for the third quarter and 9 months results. Joining us today are the following directors: Antonio Redondo, Fernando ...
The Manila Times

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activityFinal ADAPT SC+ results show ...

9 Grocery Store Frozen Chicken Burritos, Ranked Worst To Best

Frozen chicken burritos are a lifesaver when the craving strikes, but some hit the spot better than others. We've ranked nine ...

Novartis Pharma AG: Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren's disease Phase III trials

NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit1 Data showed consistent improvements across secondary outcome measures, and ...